Skip to content

To study the effect of Vidanga capsules in high cholesterol condition

To study the efficacy of Vidanga extract capsules in dyslipidaemia w.s.r. to Shonitabhishyanda- A double blind randomized controlled clinical trial - Nil

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099267
Enrollment
80
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E65-E68- Overweight, obesity and other hyperalimentation

Interventions

None listed

Sponsors

Dr Sowmya Bhat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals diagnosed with dyslipidaemia Age group 35 to 60 years of age Subjects willing to give written consent

Exclusion criteria

Exclusion criteria: Hypertension Diabetes mellitus Hypothyroidism Pregnancy and lactation Other systemic illnesses and addictions

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Vidanga extract in dyslipidaemiaTimepoint: 2 months sample size 40

Secondary

MeasureTime frame
Secondary Objectives: a) To study the efficacy of Vidanga extract on anthropometric parameters b) To study the efficacy of Vidanga extract on quality of lifeTimepoint: Duration of study: 2 months

Countries

India

Contacts

Public ContactDr Sowmya Bhat

SDM College of Ayurveda Hospital and Research Centre Kuthpady Udupi

sapre.soumya@gmail.com9900846287

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026